A randomized, double-blind clinical trial (NCT03100786) is currently being conducted to verify the efficacy of adjunctive dexamethasone in HIV-negative patients with TBM, stratified by LTA4H genotype [224]. This evidence concerns the gene LTA4H and meningeal tuberculosis.